Xp11 Translocation Renal Cell Carcinoma: Delayed but Massive and Lethal Metastases of a Chemotherapy-Associated Secondary Malignancy

Urology

Volumn 70, Issue 1, 2007, Pages 178.e3-178.e6

  Rais Bahrami, Soroush ^a   Drabick, Joseph J ^b   De Marzo, Angelo M ^a   Hicks, Jessica ^a   Ho, Clement ^c   Caroe, Alan E ^d   Argani, Pedram ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^c York Oncologic Associates   (United States)

^d YORK HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DOXORUBICIN; SORAFENIB; SUNITINIB; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TFE3; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BONE SCINTISCANNING; CANCER MORTALITY; CANCER RECURRENCE; CASE REPORT; CHILD; CHROMOSOME TRANSLOCATION; CHROMOSOME XP; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE CARDIOMYOPATHY; GENE FUSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LETHALITY; MALE; METASTASIS; NEUROECTODERM TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SECOND CANCER;

EID: 34447518538     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.03.037     Document Type: Article

References (9)

1. Argani P., and Ladanyi M. The evolving story of renal translocation carcinomas. Am J Clin Pathol 126 (2006) 1-4
2. Argani P., Laé M., Ballard E.T., et al. Translocation carcinomas of the kidney after chemotherapy in childhood. J Clin Oncol 24 (2006) 1529-1534
3. Argani P., Lal P., Hutchinson B., et al. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol 27 (2003) 750-761
4. Ramphal R., Pappo A., Zielenska M., et al. Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the MiT transcription factor family. Am J Clin Pathol 126 (2006) 1-16
5. Argani P., Antonescu C.R., Illei P., et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of young people. Am J Pathol 159 (2001) 179-192
6. Geller J.I., and Dome J.S. Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma. Cancer 101 (2004) 1575-1583
7. Dal Cin P., Stas M., Sciot R., et al. Translocation (X;1) reveals metastasis 31 years after renal cell carcinoma. Cancer Genet Cytogenet 101 (1998) 58-61
8. Perot C., Bougaran J., Boccon-Gibod L., et al. Two new cases of papillary renal cell carcinoma with t(X;1)(p11;q21) in females. Cancer Genet Cytogenet 110 (1999) 54-56
9. Tsuda M., Davis I.J., Argani P., et al. TFE3 gene fusions activate MET signaling by transcriptional upregulation, defining another class of tumors as candidates for therapeutic MET inhibition. Cancer Res 67 (2007) 919-929